Clinical Trial Update: Carvedilol in Treating Hypoglycemia Unawareness [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carvedilol for hypoglycemia unawareness was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia Unawareness

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: Owen Chan, PhD | Conditions: Hypoglycemia Unawareness | Phase 2 | Status: TERMINATED | Results posted: 2020-09-09